NCT06823193 The Impact of Self-processing on Mental Time Travel
| NCT ID | NCT06823193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA |
| Condition | Brain Injuries, Focal |
| Study Type | INTERVENTIONAL |
| Enrollment | 66 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 66 participants in total. It began in 2024-12-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mental time travel (MTT) refers to the ability to project oneself backward into the past or forward into the future to envision past and future events. This study examines the role of the ventromedial prefrontal cortex (vmPFC) in orienting toward past and future events during MTT.
Eligibility Criteria
Inclusion Criteria: * the absence of general cognitive impairment, assessed by neuropsychological testing * the presence of a focal brain lesion will be adopted as an inclusion criterion for patients. Exclusion Criteria: * psychiatric disorders * multiple brain lesions
Contact & Investigator
Giuliana Vezzadini, MD
PRINCIPAL INVESTIGATOR
Istituti Clinici Scientifici Maugeri
Frequently Asked Questions
Who can join the NCT06823193 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Brain Injuries, Focal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06823193 currently recruiting?
Yes, NCT06823193 is actively recruiting participants. Contact the research team at giuliana.vezzadini@icsmaugeri.it for enrollment information.
Where is the NCT06823193 trial being conducted?
This trial is being conducted at Castel Goffredo, Italy.
Who is sponsoring the NCT06823193 clinical trial?
NCT06823193 is sponsored by Istituti Clinici Scientifici Maugeri SpA. The principal investigator is Giuliana Vezzadini, MD at Istituti Clinici Scientifici Maugeri. The trial plans to enroll 66 participants.